Cargando…
Sclerostin induced tumor growth, bone metastasis and osteolysis in breast cancer
Breast cancer is the second leading cause of cancer-related deaths among women worldwide. Many patients suffer from bone metastasis. Sclerostin, a key regulator of normal bone remodeling, is critically involved in osteolytic bone diseases. However, its role in breast cancer bone metastasis remains u...
Autores principales: | Zhu, Menghai, Liu, Changzhen, Li, Shifei, Zhang, Shudong, Yao, Qi, Song, Qingkun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595999/ https://www.ncbi.nlm.nih.gov/pubmed/28900298 http://dx.doi.org/10.1038/s41598-017-11913-7 |
Ejemplares similares
-
Sclerostin-Mediated Impaired Osteogenesis by Fibroblast-Like Synoviocytes in the Particle-Induced Osteolysis Model
por: Jagga, Supriya, et al.
Publicado: (2021) -
Sustained‐release of sclerostin single‐chain antibody fragments using poly(lactic‐co‐glycolic acid) microspheres for osteoporotic fracture repair
por: Li, Ming, et al.
Publicado: (2019) -
The link between bone-derived factors osteocalcin, fibroblast growth factor 23, sclerostin, lipocalin 2 and tumor bone metastasis
por: Martiniakova, Monika, et al.
Publicado: (2023) -
Acid-Induced Inflammatory Cytokines in Osteoblasts: A Guided Path to Osteolysis in Bone Metastasis
por: Di Pompo, Gemma, et al.
Publicado: (2021) -
The Role of Sclerostin in Bone Diseases
por: Vasiliadis, Elias S., et al.
Publicado: (2022)